Lanton Law speaks with Pharmacy Times on California's new Stop Dangerous Pharmacies Act (AB 1286). This new law aims to address understaffed chain pharmacies and reduce medication errors. Key aspects of the law included giving pharmacists more autonomy over staffing decisions, requiring reporting of unsafe conditions, and establishing a confidential medication error reporting system.
Read MoreOn October 6th, California Governor Newsom (D-CA) signed SB 41 titled Privacy: genetic testing companies.
Read MoreJennifer Nessel of Pharmacy Times has featured Lanton Law in an article titled “Legislation to Play Significant Role in Drug Pricing Across Specialty Pharmacy.”
Read MoreCalifornia’s Governor Newsom (D-CA) has made a bold budgetary proposal to become the first state in the Union to manufacture its own generic prescription drug label. The purpose behind this is to make affordable medications accessible to the state’s 40 million residents.
Read MoreOftentimes policy changes that sweep across the nation originate in policy “hot spots” like Massachusetts, California, New York, etc. This time its consumer privacy. As we rely more and more on the internet of things, artificial intelligence and fitness applications, we are unfortunately becoming more exposed to potential data breaches. If you operate in California, the California Consumer Privacy Act (CCPA) will be a defining factor in how you manage risks around consumer data.
Read More